Start-ups

A female-led start-up developing a live biotherapeutic product to address infant gut needs, has raised £1.3M ($1.5M) in equity and grant funding.  BoobyBiome, founded by scientists Dr Lydia Mapstone, Dr Sioned Jones and Tara O’Driscoll, aims to develop a novel product for babies who do not have access to the microbiome in breast milk.  Working […]

The latest cohort of companies have joined the Venture Lab acceleration programme for early-stage companies, created by non-profit foundation the BioInnovation Institute (BII). Designed to help build research-based ideas with high-growth commercial potential into viable start-ups, BII’s 12-month Venture Lab programme supports business acceleration, scientific and team development. It provides a risk-free convertible loan of […]

News round-up for 21-25 August by DDW Editor Reece Armstrong A treatment for Monkeypox, spider venom for drug discovery and funding for international start-ups are some of the stories in this week’s news round-up. Covid researchers launch Monkeypox study   A new study investigating a potential treatment for people who have been diagnosed with monkeypox has […]

A new start-up has launched with an aim of developing therapeutics that address synaptic dysfunction in patients suffering from central nervous system (CNS) disorders.   Gate Neurosciences was founded in 2019 by a team of neuroscientists with the goal of addressing the urgent need for more effective treatments for CNS disorders, and to overcome long-standing challenges […]

Three international life sciences start-ups have received investment from the BioInnovation Institute (BII).   The three new ventures were chosen as part of the BII’s focus on developing scientific initiatives across the therapeutics and health tech space.  The companies, Sevenless Therapeutics, VEIL.AI and Myopax, will receive €1.3 million and will form part of the BII’s community […]

From AI to 3D deep-learning research to biologics, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery. Owkin French-American startup, Owkin is focussed on using artificial intelligence (AI) to discover and develop better treatments for unmet medical needs, starting with the fight against cancer. Using AI, the company identifies new drug […]

A drug candidate for heart attacks which contains venom from a deadly spider has moved closer to clinical trials due to investment of $23 million.  A research team at the University of Queensland have developed a potential therapy for heart attacks and stroke which uses a molecule found in the venom of the K’gari (Fraser […]

Félix Lavoie-Pérusse is co-founder and Chief Commercial Officer of Saguaro Technologies. He tells Lu Rahman why the company wants to make drug discovery more successful with its next-generation technologies in cell culture. Saguaro partners with drug discovery scientists to convert potentially disruptive technologies into valuable cell culture products. These products aim to either help scientists […]